8:41:38 AM PDT - Monday, September 28th, 2020

Serum Institute gets approval to resume Indian trial of AstraZeneca COVID vaccine: source  

By Editor - Wed Sep 16, 1:16 am

Serum Institute of India has received Indian regulatory approval to resume local clinical trials of AstraZeneca’s potential COVID-19 vaccine, a source familiar with the matter said on Wednesday. The approval came from the Drugs Controller General of India, the source said. AstraZeneca has resumed British clinical trials of the vaccine – one of the most advanced in development for COVID-19 – after they were paused earlier this month following a serious side effect in a trial participant.

View post:

Serum Institute gets approval to resume Indian trial of AstraZeneca COVID vaccine: source

Leave a Reply

You must sign in to post a comment.